(Q79887297)
Statements
Phase 2 study of pegylated liposomal doxorubicin, vincristine, decreased-frequency dexamethasone, and thalidomide in newly diagnosed and relapsed-refractory multiple myeloma (English)
Mohamad A Hussein
Rachid Baz
Gordan Srkalovic
Neeraj Agrawal
Revathi Suppiah
Eric Hsi
Steven Andresen
Mary Ann Karam
Janice Reed
Beth Faiman
Megan Kelly
Esteban Walker